Opexa Therapeutics
0 sources
Financials
0000950170-23-009992Summary
Opexa Therapeutics is a business[1].
Key Facts
- Opexa Therapeutics is in the country of United States[2].
- Opexa Therapeutics is in the country of US[3].
- Opexa Therapeutics's instance of is recorded as business[4].
- Opexa Therapeutics's instance of is recorded as public company[5].
- Opexa Therapeutics's headquarters location is recorded as The Woodlands[6].
- Opexa Therapeutics's headquarters location is recorded as Houston[7].
- Opexa Therapeutics's stock exchange is recorded as Nasdaq[8].
- 2013-12-26 marks the founding of Opexa Therapeutics[9].
- Opexa Therapeutics's official website is recorded as http://www.opexatherapeutics.com[10].
- Opexa Therapeutics's legal form is recorded as For-Profit Corporation[11].
- Opexa Therapeutics's legal form is recorded as C5K7[12].
- Opexa Therapeutics's legal form is recorded as XTIQ[13].
Product Details
The following facts are restated verbatim from public-domain and CC0 open-data sources — every line is independently verifiable against the named source's catalog.
GLEIF Golden Copy — Level 1 entity data
-
Legal Entity Identifier (LEI): 549300BRA7GF5PCH1L04[14]
-
Registered legal name: Acer Therapeutics INC.[15]
-
Legal jurisdiction: US-DE[16]
-
GLEIF entity category: GENERAL[17]
-
Legal form (ISO 20275 ELF): XTIQ[18]
-
Entity status: ACTIVE[19]
-
LEI registration status: LAPSED[20]
-
Entity created: 2013-12-26[21]
-
LEI first registered: 2015-02-03[22]
-
LEI last updated: 2026-08-18[23]
-
LEI next renewal: 2016-01-30[24]
-
Managing LOU: 5493001KJTIIGC8Y1R12[25]
-
Registration authority: RA000602[26]
-
Authority entity ID: 5450463[27]
-
Other names: Opexa Therapeutics, Inc.[28]
-
Conformity flag: NON_CONFORMING[29]
Body
Founding
2013-12-26 marks the founding of Opexa Therapeutics[9].
Operations
Headquarters locations include The Woodlands[6], a census-designated place in the United States[30], in United States[31], founded in 1974[32] and Houston[7], a city in the United States[33], in United States[34], founded in 1836[35].
Ownership
Opexa Therapeutics's stock exchange is recorded as Nasdaq[8].